Literature DB >> 8001944

Hepatitis A seroprevalence in homosexual and heterosexual men.

R Nandwani1, S Caswell, F Boag, A G Lawrence, J C Coleman.   

Abstract

OBJECTIVE: To determine the seroprevalence of hepatitis A antibodies in homosexual and heterosexual males attending a genitourinary medicine (GUM) clinic.
DESIGN: Prospective study of male patients recruited from a GUM clinic during a 10 week period in 1993.
SETTING: Central London outpatient GUM department at Chelsea and Westminster Hospital.
SUBJECTS: 255 patients were recruited, comprising 185 homosexual and 70 heterosexual males. Ninety two men were known to be HIV-positive, of whom 89 were homosexual. MAIN OUTCOME MEASURES: Serum samples were screened for both IgM and IgG antibodies to hepatitis A by enzyme linked immunoassay. Results were matched to an anonymously completed questionnaire.
RESULTS: 81 of the 255 subjects (31.8%) had been exposed to hepatitis A, two of whom were IgM positive. There were similar hepatitis A seroprevalence rates in homosexual (32.4%) and heterosexual men (30.0%). Although 48.1% of the homosexual men were known to be HIV-positive, compared with 4.3% of the heterosexuals. Hepatitis A seroprevalence remained comparable in both groups after patients with known HIV infection were excluded from the analysis. 11.4% of the heterosexual men admitted to oral-anal sexual contact compared with 62.2% of the homosexual men. This sexual practice was not associated with antibodies or a past history of hepatitis A exposure.
CONCLUSIONS: There was no detectable difference in hepatitis A seroprevalence between male homosexual and heterosexual GUM clinic attenders, despite a much higher level of oral-anal sexual activity among the homosexual population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001944      PMCID: PMC1195276          DOI: 10.1136/sti.70.5.325

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  15 in total

1.  Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS.

Authors:  V Beral; D Bull; S Darby; I Weller; C Carne; M Beecham; H Jaffe
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

2.  Hepatitis B antigen and antibody in a male homosexual population.

Authors:  J C Coleman; M Waugh; R Dayton
Journal:  Br J Vener Dis       Date:  1977-04

3.  Hepatitis A in homosexuals.

Authors:  A Mindel; R Tedder
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-23

Review 4.  An epidemic of acute viral hepatitis in male homosexuals. Etiology and clinical characteristics.

Authors:  G Høybye; P Skinhøj; B Hentzer; V Faber; L Mathiesen
Journal:  Scand J Infect Dis       Date:  1980

5.  Antibodies to hepatitis A antigen in relation to the number of lifetime sexual partners in patients attending an STD clinic.

Authors:  E S McFarlane; J A Embil; F R Manuel; H J Thiébaux
Journal:  Br J Vener Dis       Date:  1981-02

6.  Sexual transmission of hepatitis A in homosexual men: incidence and mechanism.

Authors:  L Corey; K K Holmes
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

Review 7.  Viral hepatitis in a venereal clinic population. Relation to certain risk factors.

Authors:  B Hentzer; P Skinhøj; G Høybye; A O Nielsen; S A Kvorning; V Faber
Journal:  Scand J Infect Dis       Date:  1980

8.  Increased risk of infection with hepatitis A and B viruses in men with a history of syphilis: relation to sexual contacts.

Authors:  P Kryger; N S Pedersen; L Mathiesen; J O Nielsen
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

9.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

10.  Prevalence of antibodies to hepatitis A antigen in patients attending a clinic for treatment of sexually transmitted diseases.

Authors:  E S McFarlane; J A Embil; F R Manuel; M Gorelick
Journal:  Sex Transm Dis       Date:  1980 Apr-Jun       Impact factor: 2.830

View more
  6 in total

Review 1.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

Review 2.  Sexual transmission and prevention of the hepatitis viruses A-E and G.

Authors:  M G Brook
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

3.  Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: a case control study of heterosexual and homosexual men.

Authors:  J D C Ross; M Ghanem; A Tariq; G Gilleran; A J Winter
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

Review 4.  Sexually acquired hepatitis.

Authors:  M G Brook
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

Review 5.  Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.

Authors:  Kuan-Yin Lin; Guan-Jhou Chen; Yu-Lin Lee; Yi-Chia Huang; Aristine Cheng; Hsin-Yun Sun; Sui-Yuan Chang; Chun-Eng Liu; Chien-Ching Hung
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

6.  Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.

Authors:  Yu-Lin Lee; Kuan-Yin Lin; Chien-Yu Cheng; Chia-Wen Li; Chia-Jui Yang; Mao-Song Tsai; Hung-Jen Tang; Te-Yu Lin; Ning-Chi Wang; Yi-Chien Lee; Shih-Ping Lin; Yu-Shan Huang; Hsin-Yun Sun; Jun-Yu Zhang; Wen-Chien Ko; Shu-Hsing Cheng; Yuan-Ti Lee; Chun-Eng Liu; Chien-Ching Hung
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.